Route of Administration | Dosage Form / Strength/Composition | Non-medicinal Ingredients |
Oral | Film-coated tablet 25 mg, 100 mg | Tablet core contains: dibasic calcium phosphate anhydrous, magnesium stearate, microcrystalline cellulose, sodium starch glycolate Film-coating contains: ferrosofferic oxide/Black iron oxide, hydroxypropyl methylcellulose (HPMC) 2910/hypromellose, iron oxide red, lactose monohydrate, macrogol/polyethylene glycol (PEG) 3350, titanium dioxide, triacetin |
Description
25 mg: 8 mm round tan immediate release film-coated tablet, debossed with “Pfizer” on one side and “25” and “LLN” on the other side.
100 mg: oval (17 x 8.5 mm) lavender immediate release film-coated tablet, debossed with “Pfizer” on one side and “LLN 100” on the other side.
Packaging: LORBRENA is supplied as follows:
25 mg
- high density polyethylene bottles containing 30, 60, or 100 tablets
- aluminum foil blisters with aluminum foil backing containing 120 tablets (12 cards of 10 tablets)
100 mg
- high density polyethylene bottles containing 30, 60, or 100 tablets
- aluminum foil blisters with aluminum foil backing containing 30 tablets (3 cards of 10 tablets)